ABCB1 and chronic myelogenous leukemia, BCR-ABL1 positive: Although CML cases respond effectively to tyrosine kinase inhibitors and chemotherapy [149], multidrug resistance proteins such as MDR1, P-gp and ABCB1 play a vital role in chemoresistance [150–152].